Viewing nowMonteluKast Chewable Tablets 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201907401 · Approved 2019.10.22 · Insurance code 651205740
Relief of allergic rhinitis symptoms; prevention and ongoing treatment of asthma
This medication is used to prevent the recurrence of asthma and assist in ongoing treatment. It is also effective in relieving symptoms caused by seasonal and perennial allergic rhinitis. It primarily helps manage respiratory allergic conditions to improve the quality of life for patients.
This medicine is taken once daily. For patients with asthma, take it in the evening; for patients with allergic rhinitis, the dosing time is determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. To take this medicine, pour 1 sachet into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this medicine suspended in water for a long time. This 4 mg granule formulation may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as refrigerated or room-temperature infant food, breast milk, or porridge. Do not open the package until immediately before use. After opening, take the entire contents immediately (within 15 minutes), either mixed with infant food, breast milk, or food, or directly. Do not leave this medicine mixed with infant food, breast milk, or food for a long time; discard any remainder. Although this formulation is not intended to be mixed with beverages other than infant food or breast milk, a beverage may be taken immediately after administration. This medicine may be taken without regard to mealtimes.
Children aged 6~14 years: Chew and take 5 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew and take 4 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, once it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, once it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months to under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants younger than 12 months. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants younger than 2 years. Infants aged 6 months to under 2 years: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants younger than 6 months.
This medication is used to treat asthma and allergic rhinitis. During treatment, there may be abnormal effects on the central nervous system. If symptoms such as agitation, anxiety, depression, hallucinations, or suicidal thoughts occur, consult a physician immediately. This medication contains the artificial sweetener aspartame; therefore, patients with phenylketonuria, a genetic disorder, should avoid using it. Since lactose is included, patients with lactose intolerance or related genetic diseases should not use this medication. This medication is not used to treat acute asthma attacks; therefore, an emergency treatment medication should be used if acute symptoms appear. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should not take these medications concurrently. While using this medication, the dosage of inhaled corticosteroid preparations may be gradually reduced, but abrupt discontinuation should be avoided. Do not use it alone for the treatment of exercise-induced bronchospasm; inhaled β-agonists should be continued as needed. There is no specific antidote for overdose, so general treatment is necessary including removing the medication from the gastrointestinal tract and monitoring symptoms. If pregnant or breastfeeding, consult with a physician before taking this medication, and it should be used cautiously, especially in early pregnancy. Avoid using this medication in young children, particularly infants under 6 months, as safety and efficacy have not been established. Elderly patients can generally use it safely, but individual reactions may vary, requiring caution. During treatment, do not arbitrarily reduce or discontinue other asthma medications unless directed by a physician. If psychiatric symptoms occur while taking this medication, notify a physician immediately, especially if there are changes in behavior or suicidal thoughts. Keep out of reach of children, and avoid transferring to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air, moisture, and light, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to preserve its effectiveness.
Pink chewable tablets with a biconvex elliptical shape
For domestic use - 28 tablets/box [(7 tablets/PTP)x4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.